POAI Predictive Oncology Inc. Net Sales Margin

Public company logo of Predictive Oncology Inc. (POAI)

The global expansion of Predictive Oncology (POAI) is constrained by export controls and supply chain disruptions from Asia. Adjusted net profit margins reflect the impact of unique AI algorithms on service costs for pharma behemoths, with the current metric standing at -11604.30. However, high R&D costs are leading to a liquidity shortage and a rapid burn rate of the company's existing cash reserves.

Predictive Oncology Inc (POAI) Net Return on Sales: for the period 07/04/2022 - 12/12/2025

Summary analytical data breakdowns for Predictive Oncology Inc. (POAI)

- market value and analyst target forecast:
General company analysis:Predictive Oncology
Manufactured product of predictive-oncology.com

For Predictive Oncology (POAI), the net margin percentage reflects the portion of profit derived from every dollar of revenue. This indicator reveals hidden efficiency degradation, where a decline in profitability despite stable sales signals a systemic crisis. The metric is sensitive to the inflation of operating expenses relative to income. Given the dependence on the R&D budgets of pharma behemoths, cost control becomes critical. The technological superiority of the AI platform allows the business to remain within a safe range.

Who Predictive Oncology competes with